Alzheimer’s ravages the minds of over 40 million victims worldwide. Join scientists as they untangle the cause of this tragic illness, and go behind the scenes of major drug trials to discover the therapies that may slow and even prevent the disease.
Dr. Sudha Seshadri, an investigator at Boston University Alzheimer’s Disease Center and Framingham Heart Study, along with colleagues published a paper in The New England Journal of Medicine. The paper is titled, Incidence of Dementia over Three Decades in the Framingham Heart Study. Click Here for Full Transcript
Dr. Jesse Mez, Associate Director of the Clinical Core at Boston University Alzheimer’s Disease Center was presented with a check from the Alzheimer’s Association to support his research in genetics.
Stern describes the project as “the biggest study of CTE in living subjects to date, in terms of the scope of the science, the number of participants, the breadth and depth and size of the group of investigators, and the amount of the grant.”
Dr. Ann McKee, Neuropathology Core Director and Associate Director of the Boston University Alzheimer’s Disease Center/ CTE Program along with colleagues published a paper introducing evidence from their first NINDS/NIBIB consensus meeting that defined neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Click Here for Publication
There is good news and bad news when it comes to aging wisely. First, the bad news: no magic pill portion can keep you physicaly and mentally robust into your golden years. The good news is Veterans have Dr. Maureen O’Connor on their side, helping them understand what normal aging is like providing tips to […]